Tag: Eleusian Biosciences - Psychedelic Alpha

Introducing Pα+: learn more and subscribe today.

GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences

Post published:July 23, 2020
Post category:Press Release

GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

Post published:July 21, 2020
Post category:Press Release

Interview with GreenStar Biosciences and Eleusian Biosciences, Following Acquisition Announcement

Post published:June 17, 2020
Post category:Interview

End of content

No more pages to load

Psychedelic Alpha

Psychedelic Alpha is an independent newsletter and community that strives to empower a diverse constellation of individuals and organisations with the knowledge, network and nuance to make an impact within the field of psychedelic medicine and beyond

Quick Links

Insights
Jobs
Data
Subscribe to Pα+
Contact

Insights and interviews delivered to your inbox. No spam, just valuable information.

GreenStar Biosciences Announces Filing of Third Provisional Patent Application by Eleusian Biosciences

GreenStar Biosciences Signs Definitive Agreement to Acquire 100% of Eleusian Biosciences Corp.

Interview with GreenStar Biosciences and Eleusian Biosciences, Following Acquisition Announcement

Psychedelic Alpha

Quick Links

Newsletter

Join Our Newsletter

Subscribe to Pα+

Consider subscribing Pα+ for exclusive insights, interviews and analysis.

No thanks, continue to site.